Cao, Yingdan, Fenghao Shi, Yuantong Li, Xiaoxia Wei, Hongbin Yi, and Sheng Han. “Cost-Effectiveness Analysis of the Combination of Low-Dose Nivolumab With Triple Metronomic Chemotherapy for Advanced Head and Neck Squamous Cell Carcinoma in China”. Health Decision 2, no. S1 (July 12, 2024). Accessed May 2, 2025. https://www.hksmp.com/journals/hd/article/view/654.